COMPANY OVERVIEW
THE PHARMAWORLD VISION
The PharmaWorld’s vision is to source leading pathology diagnostic, screening and monitoring technologies across the world and integrate it to patient pathways – for pathology is information business.
The PharmaWorld SA specialises in providing a single distribution hub for the African continent of EU or FDA registered advanced medical devices with cloud based disease prevention and management platforms from manufacturers and software houses that integrate primarily mobile smart phone diagnostic technologies
Our turnkey services to our manufacturing partners provide the following benefits:
- Development and implementation of market entry strategies
- Product registration with local health authorities
- Channel development in wellness and disease management
- Telemedicine implementation
- Warehouse distribution facilities
- Product Support
HOW WE ARE REVOLUTIONISING PATHOLOGY
Telemedicine refers to the delivery of healthcare services via an electronic device. It involves the use of telecommunications and mobile technology to deliver pathology outside of traditional healthcare facilities.
Telemedicine benefits include:
- Increased use of point of care testing (POCT), where the use of compact diagnosis instruments make it easier for patients to be tested and treated in a single treatment visit to their GP or clinic.
- Reduced need for repeat GP and hospital treatments
- Patients such as the chronically ill or the elderly may receive guidance in certain procedures while remaining at home
- Improved patient compliance through spot diagnosis
- Reduced risk of transmission such as sexually transmitted infections (STIs) and Methicillin-resistant Staphylococcus aureus (MRSA)
- Telemedicine has also made it easier for health care workers in remote field settings to obtain guidance from professionals elsewhere in diagnosis, care and referral of patients.
- Training can sometimes also be delivered via telemedicine schemes or with related technologies such as eHealth, which make use of small computers and internet.
- Well-designed telemedicine schemes can improve health care access and outcomes, particularly for chronic disease treatment and for vulnerable groups. Not only do they reduce demands on crowded facilities, but they also create cost savings and make the health sector more resilient.
- Since remote communication and treatment of patients reduces the number of visits for health services, both transport-related emissions and emissions related to operational requirements are reduced.
- In addition, fewer space demands can potentially result in smaller health facilities, with concurrent reductions in construction materials, energy and water consumption, waste, and overall environmental impact.